Last reviewed · How we verify
NCT04311268
Follow Fever to Decide
NA trial testing F2D armband in Body Temperature Changes in 306 participants. Completed in 18 December 2021.
18 December 2021
Quick facts
| Lead sponsor | Slb Pharma |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 306 |
| Start date | 13 March 2020 |
| Primary completion | 18 December 2021 |
| Estimated completion | 18 December 2021 |
| Sites | 1 location across France |
Drugs / interventions tested
- F2D armband
Conditions studied
- Body Temperature Changes — all drugs for Body Temperature Changes →
Sponsor
Slb Pharma
Who can join
Adults 18 to 80, any sex, with Body Temperature Changes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Body temperature is one of the markers of biological rhythms. The precise determination of the functioning of the biological clock for an individual is essential to understanding his physiological state at a given time. This condition is dependent on the "timing" of its central clock on the time scale (chronotype). The provision of a simple-to-use (F2D cuff), non-invasive and time-dependable temperature tool and the creation of appropriate algorithms would allow access to the operation of the central clock and open up many therapeutic applications.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04311268
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Body Temperature Changes
Currently open trials in the same condition.
- NCT06432491 — The Association Between Core Temperature and Health · NA · recruiting
- NCT06556628 — Tympanic Thermometer Study · active not recruiting
Other Slb Pharma trials
Trials by the same sponsor.
- NCT07063810 — NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Multicenter, Controlled, Randomized, Open Study. · NA · not yet recruiting
- NCT05368922 — Upper Limb Rehabilitation Using Virtual Reality in Children With Cerebral Palsy (RV-REEDUC) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04311268 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Slb Pharma
- Last refreshed: 7 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04311268.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing